Data / Drug companies / Authorized generics (NDA)
Companies that list authorized generics (nda) products: 173 companies and 1,176 products in the FDA NDC directory
The FDA National Drug Code Directory lists 1,176 products that are authorized generics marketed under a new drug application from 173 companies. The ten largest listers hold 40.0% of them, and the newest started marketing on October 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies
- 173
- Products
- 1,176
- Drugs by generic name
- 310
- Main marketing category
- Authorized generics (NDA)
Companies with the most authorized generics (nda)
Ranked by number of products in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Prasco Laboratories | 97 | tablet, film coated; tablet, coated | Authorized generics (NDA) | April 6, 2026 |
| Mylan Pharmaceuticals Inc. | 77 | tablet; tablet, film coated | Authorized generics (NDA) | August 3, 2026 |
| Sandoz Inc | 59 | capsule, extended release; patch, extended release | Authorized generics (NDA) | October 1, 2026 |
| A-S Medication Solutions | 53 | tablet; tablet, film coated | Authorized generics (NDA) | June 24, 2024 |
| Oceanside Pharmaceuticals | 50 | tablet; gel | Authorized generics (NDA) | June 29, 2026 |
| Bryant Ranch Prepack | 32 | tablet; capsule, extended release | Authorized generics (NDA) | March 24, 2022 |
| Remedyrepack Inc. | 31 | capsule, extended release; tablet | Authorized generics (NDA) | September 21, 2026 |
| Ani Pharmaceuticals, Inc. | 28 | tablet; capsule, extended release | Authorized generics (NDA) | September 5, 2024 |
| Teva Pharmaceuticals USA, Inc. | 24 | tablet; kit | Authorized generics (NDA) | January 5, 2021 |
| Asclemed USA, Inc. | 19 | tablet; injection | Authorized generics (NDA) | September 5, 2024 |
| Lannett Company, Inc. | 18 | tablet; capsule, extended release | Authorized generics (NDA) | August 3, 2020 |
| Amneal Pharmaceuticals NY LLC | 17 | tablet; spray, metered | Authorized generics (NDA) | May 15, 2026 |
| Bausch & Lomb Americas Inc. | 17 | solution/ drops; solution | Authorized generics (NDA) | January 9, 2026 |
| Bryant Ranch Prepack | 17 | tablet; tablet, film coated | Authorized generics (NDA) | January 3, 2024 |
| Advanced Rx of Tennessee, LLC | 16 | tablet; system | Authorized generics (NDA) | April 18, 2025 |
| Fresenius Kabi USA, LLC | 16 | injection | Authorized generics (NDA) | June 18, 2019 |
| Rhodes Pharmaceuticals LLC | 16 | capsule, extended release; patch | Authorized generics (NDA) | April 1, 2020 |
| Sanofi-Aventis U.S. LLC | 15 | injection; injection, solution, concentrate | Authorized generics (NDA) | July 14, 2023 |
| Sportpharm LLC | 15 | injection; powder, metered | Authorized generics (NDA) | December 2, 2024 |
| Wilshire Pharmaceuticals, Inc. | 15 | kit; capsule, delayed release | Authorized generics (NDA) | April 15, 2026 |
| Chartwell RX, LLC | 14 | capsule; tablet, film coated | Authorized generics (NDA) | April 26, 2016 |
| NuCare Pharmaceuticals,Inc. | 13 | tablet; solution/ drops | Authorized generics (NDA) | April 1, 2024 |
| Proficient Rx LP | 13 | tablet; capsule, gelatin coated | Authorized generics (NDA) | January 1, 2023 |
| Yaral Pharma Inc. | 13 | capsule; system | Authorized generics (NDA) | March 1, 2023 |
| Mylan Pharmaceuticals Inc. | 12 | cream; gel | Authorized generics (NDA) | March 20, 2025 |
| Preferred Pharmaceuticals Inc. | 12 | tablet; tablet, coated | Authorized generics (NDA) | June 8, 2026 |
| Zydus Pharmaceuticals USA Inc. | 12 | capsule, extended release; tablet, film coated, extended release | Authorized generics (NDA) | October 20, 2025 |
| Actavis Pharma, Inc. | 11 | capsule, gelatin coated; tablet | Authorized generics (NDA) | October 3, 2016 |
| Hikma Pharmaceuticals USA Inc. | 11 | tablet, film coated, extended release; tablet, film coated | Authorized generics (NDA) | December 15, 2025 |
| Northwind Health Company, LLC | 11 | tablet | Authorized generics (NDA) | March 30, 2023 |
| Padagis Israel Pharmaceuticals Ltd | 11 | tablet, film coated; ointment | Authorized generics (NDA) | April 8, 2016 |
| Aphena Pharma Solutions - Tennessee, LLC | 10 | tablet; tablet, film coated | Authorized generics (NDA) | September 24, 2025 |
| Mayne Pharma | 10 | gel; cream | Authorized generics (NDA) | May 19, 2025 |
| Neos Therapeutics, LP | 10 | tablet, orally disintegrating; suspension, extended release | Authorized generics (NDA) | July 1, 2026 |
| Padagis US LLC | 10 | patch; tablet | Authorized generics (NDA) | October 31, 2023 |
| Rising Pharma Holdings, Inc. | 10 | tablet; tablet, chewable | Authorized generics (NDA) | February 1, 2024 |
| Bryant Ranch Prepack | 9 | tablet; capsule | Authorized generics (NDA) | April 15, 2022 |
| Sandoz Inc | 9 | solution/ drops; suspension/ drops | Authorized generics (NDA) | September 30, 2011 |
| TruPharma, LLC | 9 | patch; solution | Authorized generics (NDA) | March 30, 2026 |
| Amneal Pharmaceuticals of New York LLC | 8 | capsule, extended release; injection | Authorized generics (NDA) | March 1, 2019 |
| Golden State Medical Supply, Inc. | 8 | tablet; capsule, gelatin coated | Authorized generics (NDA) | January 20, 2023 |
| Proficient Rx LP | 8 | tablet; tablet, film coated, extended release | Authorized generics (NDA) | October 1, 2016 |
| Zydus Lifesciences Limited | 8 | tablet; tablet, film coated, extended release | Authorized generics (NDA) | October 31, 2024 |
| Direct_Rx | 7 | tablet; capsule, extended release | Authorized generics (NDA) | January 16, 2025 |
| Novocol Pharmaceutical of Canada, Inc. | 7 | injection, solution | Authorized generics (NDA) | April 4, 2016 |
| Sun Pharmaceutical Industries, Inc. | 7 | capsule; cream | Authorized generics (NDA) | May 22, 2021 |
| Upsher-Smith Laboratories, LLC | 7 | capsule, extended release; gel | Authorized generics (NDA) | July 7, 2014 |
| Advagen Pharma Ltd | 6 | tablet; solution | Authorized generics (NDA) | October 1, 2026 |
| BioComp Pharma, Inc. | 6 | tablet, delayed release; tablet | Authorized generics (NDA) | September 1, 2026 |
| Coupler LLC | 6 | tablet | Authorized generics (NDA) | August 21, 2026 |
| Dr. Reddy's Laboratories Inc. | 6 | patch; capsule, gelatin coated | Authorized generics (NDA) | January 1, 2023 |
| Proficient Rx LP | 6 | tablet; aerosol, metered | Authorized generics (NDA) | January 1, 2023 |
| Trigen Laboratories, LLC | 6 | capsule; tablet, extended release | Authorized generics (NDA) | June 23, 2022 |
| USAntibiotics, LLC | 6 | for suspension; tablet, coated | Authorized generics (NDA) | December 15, 2025 |
| Noven Therapeutics, LLC | 5 | film, extended release | Authorized generics (NDA) | January 1, 2018 |
| Redpharm Drug | 5 | tablet; for suspension | Authorized generics (NDA) | September 19, 2022 |
| Alvogen Inc. | 4 | capsule; tablet, film coated, extended release | Authorized generics (NDA) | September 18, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 4 | tablet; capsule, gelatin coated | Authorized generics (NDA) | December 27, 1996 |
| Apotex Corp. | 4 | tablet, film coated, extended release; emulsion | Authorized generics (NDA) | February 7, 2022 |
| Asclemed USA Inc. | 4 | tablet; for suspension | Authorized generics (NDA) | April 1, 2024 |
| Glenmark Pharmaceuticals Inc., USA | 4 | tablet, film coated | Authorized generics (NDA) | March 19, 2026 |
| Lupin Pharmaceuticals, Inc. | 4 | capsule; emulsion | Authorized generics (NDA) | May 11, 2022 |
| Mylan Institutional LLC | 4 | injection, solution | Authorized generics (NDA) | January 5, 2015 |
| Pacific Pharma, Inc. | 4 | solution/ drops; gel | Authorized generics (NDA) | October 18, 2017 |
| Par Health USA, LLC | 4 | capsule, gelatin coated; suspension | Authorized generics (NDA) | March 29, 2023 |
| Sina Health Inc | 4 | injection | Authorized generics (NDA) | December 15, 2016 |
| Uronova Pharmaceuticals, Inc. | 4 | injection, suspension, extended release | Authorized generics (NDA) | December 15, 2025 |
| Airgas Usa, LLC | 3 | gas | Authorized generics (NDA) | January 3, 2012 |
| American Health Packaging | 3 | tablet; solution | Authorized generics (NDA) | September 1, 2021 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet | Authorized generics (NDA) | February 27, 2013 |
| Ascend Laboratories, LLC | 3 | capsule | Authorized generics (NDA) | March 3, 2021 |
| Atlantic Biologicals Corp. | 3 | suspension; solution | Authorized generics (NDA) | October 31, 2023 |
| Cardinal Health 107, LLC | 3 | tablet; patch | Authorized generics (NDA) | April 1, 2015 |
| Currax Pharmaceuticals LLC DBA Cypress, Hawthorn, Macoven | 3 | tablet | Authorized generics (NDA) | May 14, 2015 |
| Dr. Reddy's Laboratories Inc. | 3 | solution/ drops; capsule, delayed release pellets | Authorized generics (NDA) | July 6, 2025 |
| Edenbridge Pharmaceuticals LLC. | 3 | tablet | Authorized generics (NDA) | October 15, 2015 |
| Foundation Consumer Healthcare | 3 | tablet | Authorized generics (NDA) | June 15, 2019 |
| Fresenius Kabi USA, LLC | 3 | injection; injection, solution | Authorized generics (NDA) | June 22, 2023 |
| Ingenus Pharmaceuticals, LLC | 3 | tablet, orally disintegrating | Authorized generics (NDA) | September 15, 2025 |
| Omnivium Pharmaceuticals LLC. | 3 | tablet; solution | Authorized generics (NDA) | May 2, 2024 |
| Pacific Pharma, Inc. | 3 | solution/ drops; suspension | Authorized generics (NDA) | February 1, 2024 |
| Par Health USA, LLC | 3 | capsule | Authorized generics (NDA) | March 28, 2016 |
| Phoenix RX LLC | 3 | system; capsule, extended release | Authorized generics (NDA) | November 18, 2022 |
| St. Mary's Medical Park Pharmacy | 3 | tablet; patch | Authorized generics (NDA) | June 9, 2026 |
| Upsher-Smith Laboratories, LLC | 3 | tablet, film coated, extended release | Authorized generics (NDA) | April 25, 2024 |
| Wal-Mart Stores Inc | 3 | patch, extended release | Authorized generics (NDA) | October 19, 2010 |
| Actavis Pharma, Inc. | 2 | tablet, film coated | Authorized generics (NDA) | September 13, 2011 |
| Affordable Pharmaceuticals, LLC | 2 | powder, for solution | Authorized generics (NDA) | February 8, 2013 |
| Aira LLC | 2 | injection | Authorized generics (NDA) | September 15, 2026 |
| Allegis Pharmaceuticals, LLC | 2 | spray; suspension | Authorized generics (NDA) | July 1, 2019 |
| Asegua Therapeutics LLC | 2 | tablet, film coated | Authorized generics (NDA) | January 1, 2019 |
| AstraZeneca Pharmaceuticals LP | 2 | aerosol | Authorized generics (NDA) | January 3, 2020 |
| Baxter Healthcare Corporation | 2 | injection, suspension, liposomal | Authorized generics (NDA) | August 15, 2019 |
| Benco Dental | 2 | injection, solution | Authorized generics (NDA) | April 4, 2016 |
| Burkhart Dental Supply Inc | 2 | injection, solution | Authorized generics (NDA) | November 4, 2024 |
| Cima Labs Inc. | 2 | tablet | Authorized generics (NDA) | March 29, 2012 |
| Coral Way Pharma, LLC | 2 | capsule; lotion | Authorized generics (NDA) | March 10, 2026 |
| Dentsply Pharmaceutical | 2 | injection, solution | Authorized generics (NDA) | September 1, 2009 |
| Genus Lifesciences | 2 | tablet; solution | Authorized generics (NDA) | August 10, 2022 |
| H2-Pharma, LLC | 2 | capsule | Authorized generics (NDA) | July 1, 2025 |
Drugs most often listed
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.